GenoGlyph: Pan-cancer genomic mutation inference and risk stratification from diagnostic histopathology slides.
Artificial intelligence can predict a cancer's molecular profile directly from standard tissue slides, potentially bringing precise diagnosis to under-resourced settings.
GenoGlyph, a deep learning model, infers pan-cancer genomic mutations and performs risk stratification directly from standard diagnostic histopathology slides without requiring molecular testing. This approach could democratize molecular risk assessment in resource-limited settings where sequencing is unavailable.
What the study was
- Study design
- deep_learning_model_pan_cancer
- Category
- precision_oncology
- Maturity
- Exploratory
Why it surfaced
Potentially disruptive approach inferring genomics from histology—directly relevant to precision oncology and AI diagnostics watchlists. Could make molecular profiling accessible without additional testing cost. Research Square preprint—score capped at 6 per preprint policy.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.